Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to accept or reject the hypothesis that Lu AE58054 improves
cognition and functional outcomes in patients with moderate Alzheimer's Disease, already in
treatment with donepezil.